This inventor holds 2 USPTO granted patents, plus 1 CIPO patent. Top assignee: Chiesi Farmaceutici S.p.a.. Active years: 2010-2012.
Company Filing History:
Years Active: 2010-2012
As an AI assistant focusing on innovations, inventions, inventors, patent attorneys, assignees, and patents, I can help you with that. Here is the article about inventor Andrea Capocchi:
Title: Unveiling Andrea Capocchi: Innovating Pharmaceutical Processes in Parma
Introduction:
Andrea Capocchi, a brilliant inventor based in Parma, Italy, is making notable strides in pharmaceutical innovations. With a keen focus on developing processes for sterile aqueous suspensions and inclusion compounds, Capocchi's contributions are reshaping the industry.
Latest Patents:
1. "Preparation of Sterile Aqueous Suspensions Comprising Micronised Crystalline Active Ingredients for Inhalation": This patent discloses a process for preparing sterile aqueous suspensions based on micronised crystalline particles for inhalation delivery, enhancing drug administration efficiency.
2. "Process for the Preparation of Piroxicam: β-Cyclodextrin Inclusion Compounds": Capocchi's innovative process involves creating inclusion compounds of piroxicam with β-cyclodextrin, optimizing physico-chemical properties for oral pharmaceutical compositions.
Career Highlights:
Working at Chiesi Farmaceutici S.p.A., a renowned pharmaceutical company, Andrea Capocchi demonstrates his expertise in advancing pharmaceutical processes. His dedication to innovation and quality has significantly impacted drug development methodologies.
Collaborations:
Collaborating with Fausto Pivetti, a talented woman professional, Andrea Capocchi fosters a creative and dynamic work environment. Their partnership exemplifies the importance of diverse perspectives in driving innovative solutions in the pharmaceutical field.
Conclusion:
Andrea Capocchi's inventive spirit and commitment to excellence in pharmaceutical advancements embody a continuous pursuit of better healthcare solutions. His patents and collaborations reflect a promising future for pharmaceutical innovations.
